Relapsing toxic epidermal necrolysis following COVID-19.
| Autor: | Messele F; Department of Dermatology, University of California, Irvine, Irvine, California., Horton L; Department of Dermatology, University of California, Irvine, Irvine, California., Sharma AN; Department of Dermatology, University of California, Irvine, Irvine, California., Min MS; Department of Dermatology, University of California, Irvine, Irvine, California., Rojek NW; Department of Dermatology, University of California, Irvine, Irvine, California., Linden KG; Department of Dermatology, University of California, Irvine, Irvine, California. |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | JAAD case reports [JAAD Case Rep] 2024 Jul 31; Vol. 53, pp. 23-26. Date of Electronic Publication: 2024 Jul 31 (Print Publication: 2024). |
| DOI: | 10.1016/j.jdcr.2024.07.011 |
| Abstrakt: | Competing Interests: Dr Min is on the advisory boards of Horizon, McGraw Hill, and BMS and is an investigator for Amgen, BI, MBS, and Priovant. Dr Rojek has served on the advisory board of Boehringer Ingelheim. The other authors have no conflicts of interest to declare. |
| Databáze: | MEDLINE |
| Externí odkaz: |
|